Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Raised to $244 at Goldman Sachs

April 30, 2026 4:25 AM
Goldman Sachs analyst Asad Haider raised the price target on Abbvie (NYSE: ABBV) to $244.00 (from $240.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change